The skeletal effects of thiazolidinedione and metformin on insulin-resistant mice.

The skeletal effects of thiazolidinedione and metformin on insulin-resistant mice.

Item
http://www.wikidata.org/entity/Q38322718
Metformin revisited: Does this regulator of AMP-activated protein kinase secondarily affect bone metabolism and prevent diabetic osteopathyMetformin Decreases Reactive Oxygen Species, Enhances Osteogenic Properties of Adipose-Derived Multipotent Mesenchymal Stem Cells In Vitro, and Increases Bone Density In VivoThe anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing.Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review.Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future.Metformin rescues the MG63 osteoblasts against the effect of high glucose on proliferation.Diabetes Drug Effects on the Skeleton.Correlates of fractures in elderly, diabetic outpatients.Evaluation of the anti-osteoporotic effects of metformin and sitagliptin in postmenopausal diabetic women.
P2860

The skeletal effects of thiazolidinedione and metformin on insulin-resistant mice.

Item
http://www.wikidata.org/entity/Q38322718
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The skeletal effects of thiazolidinedione and metformin on insulin-resistant mice.
@en
type
label
The skeletal effects of thiazolidinedione and metformin on insulin-resistant mice.
@en
prefLabel
The skeletal effects of thiazolidinedione and metformin on insulin-resistant mice.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
The skeletal effects of thiazolidinedione and metformin on insulin-resistant mice.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P921